Expertise in
12
conditions

Dr. Michael K. Lim

Internal Medicine
El Camino Health
2500 Grant Rd, 
Mountain View, CA 
Expertise in
12
conditions
El Camino Health
2500 Grant Rd, 
Mountain View, CA 

Overview

Michael Lim is a primary care provider, practicing in Internal Medicine in Mountain View, California.

Dr. Lim is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Trigeminal Neuralgia, Subependymoma, Acute Pain, Rhizotomy, and Microvascular Decompression.

He is actively involved in clinical research, co-authoring 402 peer reviewed articles and participating in 14 clinical trials.

Specialties

Internal Medicine

Licenses

Hospitalist in CA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Santa Clara Family Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Sutter Health
  • HMO
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Valley Health
  • HMO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

El Camino Health
2500 Grant Rd, Mountain View, CA 94040

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

A Phase I Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM
A Phase I Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM
Enrollment Status: Active_not_recruiting
Publish Date: April 23, 2026
Intervention Type: Drug
Study Drug: MBG453
Study Phase: Phase 1
A Pilot Study of Stereotactic Radiosurgical Hypophysectomy for Intractable Pain From Bone Metastases
A Pilot Study of Stereotactic Radiosurgical Hypophysectomy for Intractable Pain From Bone Metastases
Enrollment Status: Terminated
Publish Date: January 22, 2026
Intervention Type: Radiation
Study Phase: Not Applicable
Phase I Safety Study of Stereotactic Radiosurgery With Concurrent and Adjuvant PD-1 Antibody Nivolumab in Subjects With Recurrent or Advanced Chordoma
Phase I Safety Study of Stereotactic Radiosurgery With Concurrent and Adjuvant PD-1 Antibody Nivolumab in Subjects With Recurrent or Advanced Chordoma
Enrollment Status: Active_not_recruiting
Publish Date: January 06, 2026
Intervention Type: Biological, Other, Radiation
Study Drug: Nivolumab
Study Phase: Phase 1
Phase IIa Study Assessing QBS72S For Treating Brain Metastases
Phase IIa Study Assessing QBS72S For Treating Brain Metastases
Enrollment Status: Active_not_recruiting
Publish Date: December 23, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
Enrollment Status: Terminated
Publish Date: January 24, 2025
Intervention Type: Biological, Drug
Study Drugs: HSPPC-96, Bevacizumab
Study Phase: Phase 2
Randomized, Two-arm, Multicenter Study to Evaluate the Safety and Efficacy of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery
Randomized, Two-arm, Multicenter Study to Evaluate the Safety and Efficacy of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery
Enrollment Status: Completed
Publish Date: June 26, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
Enrollment Status: Suspended
Publish Date: April 03, 2024
Intervention Type: Biological
Study Phase: Phase 3
A Phase I Trial of Anti-LAG-3 or Anti-CD137 Alone and in Combination With Anti-PD-1 in Patients With Recurrent GBM
A Phase I Trial of Anti-LAG-3 or Anti-CD137 Alone and in Combination With Anti-PD-1 in Patients With Recurrent GBM
Enrollment Status: Completed
Publish Date: October 06, 2023
Intervention Type: Biological, Other
Study Drugs: Anti-LAG-3 Monoclonal Antibody BMS 986016, Anti-PD-1, Anti-CD137
Study Phase: Phase 1
A Pilot Study of Stereotactic Radiosurgery Combined With Nivolumab in Patients With Newly Diagnosed Melanoma Metastases in the Brain and Spine
A Pilot Study of Stereotactic Radiosurgery Combined With Nivolumab in Patients With Newly Diagnosed Melanoma Metastases in the Brain and Spine
Enrollment Status: Completed
Publish Date: November 30, 2021
Intervention Type: Radiation, Biological, Other
Study Drug: Nivolumab
Study Phase: Phase 1
A Pilot Study to Assess Feasibility of 5 Fraction Hypofractionated Stereotactic Radiosurgery Along With Standard Temozolomide as a Lymphocyte Sparing Therapy for Glioblastoma Multiforme
A Pilot Study to Assess Feasibility of 5 Fraction Hypofractionated Stereotactic Radiosurgery Along With Standard Temozolomide as a Lymphocyte Sparing Therapy for Glioblastoma Multiforme
Enrollment Status: Completed
Publish Date: November 19, 2021
Intervention Type: Drug
Study Phase: Early Phase 1
View 9 Less Clinical Trials

402 Total Publications

Fall Risk Identification with Innovative Technologies for Aging in Place: A Clinical Needs Assessment Study.
Fall Risk Identification with Innovative Technologies for Aging in Place: A Clinical Needs Assessment Study.
Journal: Canadian geriatrics journal : CGJ
Published: September 01, 2026
Similar Doctors
Expertise in
19
conditions
Dr. Stephen P. Luby
Internal Medicine
Expertise in
19
conditions
Dr. Stephen P. Luby
Internal Medicine

Office

473 Via Ortega # Y2, 
Stanford, CA 
 (6.0 miles away)
650-723-4129
Languages Spoken:
English

Stephen Luby is a primary care provider, practicing in Internal Medicine in Stanford, California. Dr. Luby is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Diarrhea, Parainfluenza, Typhoid Fever, and Salmonella Enterocolitis.

Expertise in
20
conditions
Dr. Eri Fukaya
Internal Medicine
Expertise in
20
conditions
Dr. Eri Fukaya
Internal Medicine

Stanford Hospital And Clinics

965 High St, 
Palo Alto, CA 
 (6.5 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Eri Fukaya is a primary care provider, practicing in Internal Medicine in Palo Alto, California. Dr. Fukaya is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Varicose Veins, Venous Insufficiency, Peripheral Artery Disease, Stasis Dermatitis and Ulcers, and Thrombectomy.

Expertise in
26
conditions
Dr. Monique T. Barakat
Internal Medicine
Expertise in
26
conditions
Dr. Monique T. Barakat
Internal Medicine
Before you request

Stanford Hospital And Clinics

300 Pasteur Dr, 
Stanford, CA 
 (6.8 miles away)
650-723-6661
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Monique Barakat is a primary care provider, practicing in Internal Medicine in Stanford, California. Dr. Barakat is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Childhood Pancreatitis, Bile Duct Obstruction, Cholestasis, Endoscopy, and Gallbladder Removal. Dr. Barakat is currently accepting new patients.

Frequently Asked Questions about Dr. Michael K. Lim

How do I make an appointment with Dr. Michael K. Lim?

You can book an appointment with Dr. Michael K. Lim by calling their office at 408-739-6000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Michael K. Lim a top-rated expert for Rhizotomy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael K. Lim is classified as an Elite expert for Rhizotomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michael K. Lim specialize in?

While Dr. Michael K. Lim is a Internal Medicine, they have specific expertise in Rhizotomy, Trigeminal Neuralgia, and Microvascular Decompression. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Michael K. Lim participate in research or clinical trials?

Yes. Dr. Michael K. Lim has published 402 articles and abstracts on conditions like Rhizotomy. You can view a list of Dr. Michael K. Lim's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Michael K. Lim accept my insurance?

Dr. Michael K. Lim accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 408-739-6000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lim's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 45 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile